{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:16:23Z","timestamp":1792664183353,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":4848,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1111\/j.1538-7836.2009.03532.x","type":"journal-article","created":{"date-parts":[[2009,6,27]],"date-time":"2009-06-27T02:54:25Z","timestamp":1246071265000},"page":"1517-1522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Faster onset of effect and greater efficacy of NN1731 compared with rFVIIa, aPCC and FVIII in tail bleeding in hemophilic mice"],"prefix":"10.1016","volume":"7","author":[{"given":"H.L.","family":"HOLMBERG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"LAURITZEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"TRANHOLM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"EZBAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0010","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1055\/s-0037-1615388","article-title":"Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors","volume":"80","author":"Key","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2516.2007.01601.x","article-title":"Single 270 mu g kg(\u20101)\u2010dose rFVIIa vs. standard 90 mu g kg(\u2010 1)\u2010dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison","volume":"14","author":"Young","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0020","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.CCM.0000159087.85970.38","article-title":"Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review","volume":"33","author":"Levi","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0025","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2004-06-2223","article-title":"The use of recombinant factor VIIa in the treatment of bleeding disorders","volume":"104","author":"Roberts","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1538-7836.2006.01772.x","article-title":"A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors","volume":"4","author":"Santagostino","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1538-7836.2003.00059.x","article-title":"A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven)","volume":"1","author":"Kenet","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0040","first-page":"14","article-title":"The action of high\u2010dose factor VIIa (FVIIa) in a cell\u2010based model of hemostasis","volume":"49","author":"Hoffman","year":"2003","journal-title":"Dis Mon"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high\u2010dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0050","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1538-7836.2007.02308.x","article-title":"Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface","volume":"5","author":"Ghosh","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0055","doi-asserted-by":"crossref","first-page":"13583","DOI":"10.1073\/pnas.241339498","article-title":"Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity","volume":"98","author":"Persson","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1538-7836.2008.02933.x","article-title":"Recombinant human factor VIIa and a factor VIIa\u2010analogue reduces heparin and low molecular weight heparin (LMWH)\u2010induced bleeding in rats","volume":"6","author":"Lauritzen","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0065","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2003-05-1369","article-title":"Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A","volume":"102","author":"Tranholm","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1538-7836.2009.03287.x","article-title":"rFVIIa and a new enhanced rFVIIa\u2010analogue, NN1731, reduce bleeding in clopidogrel\u2010treated, in thrombocytopenic rats","volume":"7","author":"Lauritzen","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.ATV.0000257204.82396.2b","article-title":"A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia","volume":"27","author":"Allen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2141.2007.06534.x","article-title":"Factor VIIa analogue (V158D\/E296V\/M298Q\u2010FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A","volume":"137","author":"S\u00f8rensen","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0085","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2516.2007.01524.x","article-title":"Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients","volume":"13","author":"Brophy","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2516.2008.01870.x","article-title":"Prevention of haemarthrosis in a murine model of acute joint bleeding","volume":"15","author":"Valentino","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0095","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1055\/s-0037-1613377","article-title":"A quantitative measure of the efficacy of factor VIII in hemophilia A mice","volume":"89","author":"Parker","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0049-3848(00)00397-2","article-title":"Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor","volume":"101","author":"Elg","year":"2001","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.thromres.2004.11.003","article-title":"Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human\u2010murine species compatibility study","volume":"116","author":"Petersen","year":"2005","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0305-0491(91)90061-H","article-title":"Comparison of rat and human major platelet glycoproteins","volume":"99","author":"Holada","year":"1991","journal-title":"Comp Biochem Physiol B"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0120","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/blood-2008-02-139113","article-title":"The glycoprotein Ib\u2010IX\u2010V complex contributes to tissue factor\u2010independent thrombin generation by recombinant factor VIIa on the activated platelet surface","volume":"112","author":"Weeterings","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03532.x_bb0125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1538-7836.2008.03253.x","article-title":"Evaluation of the safety and pharmacokinetics of a fast\u2010acting recombinant FVIIa analogue, NN1731, in healthy male subjects","volume":"7","author":"M\u00f8ss","year":"2009","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2009.03532.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622124736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622124736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2009.03532.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:49:25Z","timestamp":1761533365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622124736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1538783622124736"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03532.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Faster onset of effect and greater efficacy of NN1731 compared with rFVIIa, aPCC and FVIII in tail bleeding in hemophilic mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03532.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}